Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nuclear poly(ADP-ribose) polymerase 1 (PARP-1) is a multifunctional nuclear enzyme that plays critical roles in DNA repair, chromatin remodeling, transcription regulation, and cell death pathways. It detects DNA strand breaks and synthesizes poly(ADP-ribose) (PAR) chains, signaling DNA damage and recruiting repair proteins. PARP-1 is involved in multiple DNA repair pathways and regulates transcription/chromatin structure. Inhibition of PARP-1 is a therapeutic strategy, particularly in cancers with BRCA mutations or other homologous recombination deficiencies.
Inhibition of PARP-1 enzymatic activity, leading to accumulation of DNA damage and cell death, especially in HR-deficient cells
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear poly(ADP-ribose) polymerase 1 (PARP-1).